41 studies found for:    " January 19, 2011":" February 18, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Chemotherapy for Lung Cancer in HIV-positive Patients
Conditions: Non-small Cell Lung Cancer;   Hiv-positive
Intervention: Drug: Chemotherapy
2 Completed Progression of HIV-Disease Under Low Dose Corticosteroids
Condition: HIV Disease Progression
Intervention: Drug: Prednisolone
3 Terminated Lenalidomide in Kaposi Disease Associated With HIV Infection
Condition: HIV Infection Associated Kaposi Disease
Intervention: Drug: Lenalidomide
4 Completed Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine
Condition: HIV Infections
Intervention: Biological: CN54gp140 glycoprotein-hsp70 conjugate vaccine
5 Unknown  Assessment of Normal Value of Acoustic Radiation Force Impulse (ARFI) Elastography in HIV Patients
Condition: HIV Infection
Intervention: Device: Acoustic radiation force impulse imaging
6 Unknown  Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
Condition: HIV Infection
Intervention: Biological: Hepavax-Gene
7 Completed Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
Conditions: HIV Infections;   HCV Infections
Interventions: Drug: boceprevir;   Drug: raltegravir
8 Not yet recruiting Structured Treatment Interruption (STI) in Acute/Primary HIV
Condition: HIV Infections
Intervention: Other: Gradual anti-HIV treatment interruption
9 Completed Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis
Conditions: Human Immunodeficiency Virus;   Hepatitis C
Intervention: Drug: Raltegravir 400 mg/12hours
10 Completed An Automated, Tailored Information Application for Medication Health Literacy
Condition: Human Immunodeficiency Virus I Infection
Intervention: Behavioral: Tailored Information
11 Completed Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection
Condition: HIV Infections
Intervention:
12 Unknown  Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
Condition: Kaposi´s Sarcoma
Intervention: Drug: Bevacizumab
13 Completed Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
Conditions: HIV Infection;   Hepatitis C
Interventions: Drug: Anti-HIV Agents;   Drug: raltegravir;   Drug: Emtricitabine and tenofovir disoproxil fumarate
14 Unknown  Internet-Based Sexual Health Education for Middle School Native American Youth
Conditions: Sexually Transmitted Diseases;   Pregnancy;   HIV Infections
Interventions: Behavioral: HIV, STI and Pregnancy Prevention Curriculum;   Behavioral: Control Curricula
15 Unknown  Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
Condition: HIV
Interventions: Drug: Raltegravir;   Drug: Efavirenz
16 Completed
Has Results
Immune Response After Booster Vaccination in HIV - Infected Patients Who Received Rabies Primary Vaccination
Conditions: HIV;   Rabies
Intervention: Biological: rabies vaccines on day 0 and 3
17 Active, not recruiting Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients
Condition: HIV
Intervention: Drug: MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir
18 Completed Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision
19 Recruiting Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Pegylated Interferon Alpha 2b (PEGINTRON)
20 Completed Microbicide Safety and Acceptability in Young Men
Conditions: High Risk MSM;   HIV Negative;   18-30 Years of Age
Interventions: Other: HEC Placebo Gel;   Drug: Tenofovir 1% Gel

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years